OSSIO

OSSIO is an orthopedic fixation company founded in 2014 and based in Woburn, Massachusetts, with development and manufacturing facilities in Caesarea, Israel. The company focuses on providing biologically advanced alternatives to traditional metal implants in the orthopedic fixation market, which is valued at over $15 billion. OSSIO's core innovation is its proprietary OSSIOfiber® Intelligent Bone Regeneration Technology, which combines the mechanical strength of metal with the biological benefits of natural bone healing. The OSSIOfiber® product line includes the Bone Pin Family and Compression Screw Portfolio, both of which have received FDA clearance. These implants are designed to integrate with the patient's bone, eliminating the need for hardware removal surgery and minimizing complications. OSSIO aims to improve patient outcomes and healthcare economics by offering solutions that restore stability and mobility without permanent hardware. The company has been recognized for its innovation, receiving the 2019 Frost & Sullivan New Product Innovation Award for its OSSIOfiber technology.

• Employees 140
• Founded 2014
• Annual Revenue $54600000
• Total Funding $101100000